Simplex Trading’s Co-Diagnostics CODX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-57
Closed -$286 9209
2025
Q4
$286 Buy
+57
New +$620 ﹤0.01% 8224
2024
Q1
Sell
-993
Closed -$39K 8955
2023
Q4
$39K Sell
993
-557
-36% -$19.6K ﹤0.01% 6314
2023
Q3
$49K Buy
1,550
+420
+37% +$15.9K ﹤0.01% 5818
2023
Q2
$37K Sell
1,130
-100
-8% -$3.83K ﹤0.01% 6125
2023
Q1
$54K Sell
1,230
-130
-10% -$10.4K ﹤0.01% 5828
2022
Q4
$102K Sell
1,360
-60
-4% -$5.62K ﹤0.01% 5052
2022
Q3
$136K Sell
1,420
-620
-30% -$86.7K ﹤0.01% 5093
2022
Q2
$343K Sell
2,040
-1,303
-39% -$198K ﹤0.01% 3924
2022
Q1
$619K Buy
3,343
+900
+37% +$186K ﹤0.01% 3562
2021
Q4
$654K Buy
2,443
+1,250
+105% +$328K ﹤0.01% 3456
2021
Q3
$297K Buy
1,193
+46
+4% +$13.4K ﹤0.01% 4918
2021
Q2
$283K Buy
1,147
+1,133
+8,093% +$291K ﹤0.01% 5077
2021
Q1
$386K Buy
+14
New +$5.59K ﹤0.01% 3757
2020
Q4
Sell
-36
Closed -$1.47M 8414
2020
Q3
$1.47M Buy
36
+4
+13% +$2.06K ﹤0.01% 1830
2020
Q2
$1.87M Buy
32
+6
+23% +$2.74K ﹤0.01% 1566
2020
Q1
$597K Buy
+26
New +$4.51K ﹤0.01% 2407

Other funds holding CODX

Simplex Trading's CODX Position: Q1 2026 in Review

Simplex Trading sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 325 shares — an estimated $1.64K sold.

Simplex Trading first reported a position in CODX in Q1 2020 and held it in 20 quarters. The position peaked at $328K in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Simplex Trading reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 325 Co-Diagnostics shares in Q1 2026, an estimated $1.64K.
  • Simplex Trading first reported a position in Co-Diagnostics in Q1 2020 and held it in 20 quarters.
  • Simplex Trading's Co-Diagnostics position peaked at $328K in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.